Cliff Asness's SLS Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 58,120 shares of SELLAS Life Sciences Group, Inc. (SLS) worth $857,851, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in SLS, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 4,130 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's SELLAS Life Sciences Group (SLS) Holding Value Over Time
Track share changes against reported price movement
Quarterly SELLAS Life Sciences Group (SLS) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +4,130 | Add 7.65% | 58,120 | $14.76 |
| Q1 2026 | +53,990 | New Buy | 53,990 | $4.23 |
Cliff Asness's SELLAS Life Sciences Group Investment FAQs
Cliff Asness first purchased SELLAS Life Sciences Group, Inc. (SLS) in Q1 2026, acquiring 53,990 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held SELLAS Life Sciences Group, Inc. (SLS) for 2 quarters since Q1 2026.
Cliff Asness's largest addition to SELLAS Life Sciences Group, Inc. (SLS) was in Q1 2026, adding 53,990 shares worth $228,378.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 58,120 shares of SELLAS Life Sciences Group, Inc. (SLS), valued at approximately $857,851.
As of the Q2 2026 filing, SELLAS Life Sciences Group, Inc. (SLS) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in SELLAS Life Sciences Group, Inc. (SLS) was 58,120 shares, as reported at the end of Q2 2026.